The high cost of India’s private health-care boom

GS-II: Health | Governance | Government Policies & Interventions | Accountability
GS-III: Indian Economy | Investment | Inclusive Growth

Context

• Parliamentary Committee Report: The Parliamentary Standing Committee on Health and Family Welfare, in its 176th Report, tabled on August 7, 2026, highlighted the high cost of hospitalisation in private facilities.
• Hospitalisation Cost: Average hospitalisation costs ₹50,508 in private facilities, compared with ₹6,631 in government facilities.
• Childbirth Cost: Average out-of-pocket medical expenditure for childbirth is ₹37,630 in private facilities, against ₹2,299 in public facilities.
• Recommendations: The Committee made 368 recommendations, including standardised package rates and mandatory pre-treatment cost estimates.

Major Recommendations of the Committee

• Room Tariffs: Basic room tariffs in metropolitan private hospitals should not exceed the average tariff of nearby three-star hotels.
• Cross-Subsidisation: Large corporate hospitals earning from medical tourism, foreign patients and high-net-worth individuals should cross-subsidise poorer Indians.
• AB-PMJAY: Such hospitals should reserve beds for Ayushman Bharat–Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) beneficiaries at regulated rates.
• FDI Review: The Committee has suggested reviewing FDI rules concerning the acquisition and management of existing hospitals.

Why Private Investment in Healthcare Remains Important

• Capital Intensive Sector: Hospitals require substantial capital for land, equipment, ICUs, digital systems, laboratories and trained personnel.
• Capacity Gap: Public hospitals currently cannot meet all demand for secondary and tertiary care.
• Filling the Gap: Private hospitals therefore play an important role in expanding healthcare capacity.
• Foreign Investment: Foreign investors and private-equity funds can bring:
  • Capital
  • Managerial capacity
  • Technology
  • Hospital-network expansion
• Manufacturing: India also needs investment in pharmaceutical and medical-device manufacturing.
• Risk of Excessive Regulation: Excessively restrictive or unpredictable regulation could discourage investment and slow healthcare infrastructure expansion.

The Core Contradiction

• Need for Investment: India wants greater private and foreign capital in healthcare, particularly in Tier-2, Tier-3 and rural areas.
• Regulatory Concern: At the same time, there is a demand to review FDI rules concerning the acquisition and management of existing hospitals.
• Policy Challenge: The objective should be to balance investment and expansion with affordability, competition and public interest.

Information Asymmetry in Healthcare

• Patient–Provider Information Gap: Patients generally cannot independently determine whether an MRI, hospital admission, additional treatment or particular procedure is medically necessary.
• Information Asymmetry: Healthcare providers possess greater technical knowledge than patients.
• Risk: Strong financial incentives may influence not only the price of healthcare, but also the quantity of healthcare delivered.
• Key Concern: When providers are rewarded for doing more, there may be incentives towards unnecessary prescriptions, surgeries, investigations and medications.

Private Equity and Corporate Healthcare

• Specialists and Technology: Corporate hospital groups increasingly compete for well-known specialists, sophisticated technology and premium infrastructure.
• Cost Recovery: High salaries, expensive equipment and revenue pressures can increase the cost structure of hospitals.
• Institutional Incentives: Revenue targets, procedure-linked incentives, higher occupancy expectations and higher revenue per bed may influence institutional behaviour.
• Medicalisation: Excessive focus on interventions may contribute to:
  • Unnecessary follow-up tests
  • Hospitalisation where outpatient management may suffice
  • Excessive investigations
  • Higher use of procedures and medicines
• Important Qualification: These interventions are not necessarily unnecessary; the concern is the incentive structure surrounding them.

Why FDI in Existing Hospitals Needs Scrutiny

The relevant question should not simply be whether investment is foreign or domestic, but what the investment does to the healthcare system.

• New Capacity: Does it create new beds, or merely acquire existing ones?
• Competition: Does it improve competition or increase market concentration?
• Geographical Equity: Does it enter an underserved district or add another high-end facility in a metropolitan area?
• Public Support: If investors receive concessional land, tax benefits or other public support, are there enforceable obligations regarding:
  • Affordable beds
  • Participation in public insurance schemes
• Policy Direction: India should encourage greenfield investment and manufacturing, while scrutinising acquisitions that may reduce competition or increase excessive pricing.

Concerns with Price Regulation

• Three-Star Hotel Benchmark: Linking hospital room charges to nearby three-star hotel tariffs is easy to understand but cannot alone solve affordability.
• Different Cost Structure: Hospital rooms involve nursing, infection control and emergency support, unlike hotel rooms.
• Regulatory Arbitrage: If one component of the bill is capped, hospitals may increase charges elsewhere.
• Coronary Stents: India’s experience with coronary stent price regulation demonstrates that government intervention can reduce excessive mark-ups.
• Healthcare Complexity: Hospital care is more complex; therefore, the focus should be on the total cost of the treatment episode.

Diagnosis-Related Groups (DRG)

• Meaning: DRG is a patient-classification system used to standardise hospital reimbursement.
• Fixed Payment: Hospitals receive a fixed, predetermined amount for an inpatient stay based on the diagnosis and procedures.
• Alternative to Fee-for-Service: Payment is linked to the treatment episode, rather than reimbursing every individual service separately.
• Relevance: DRG can help address incentives for excessive provision of individual services.

Focus on Public Healthcare

• Regulation Alone Is Insufficient: India cannot regulate its way out of weak public healthcare.
• Dependence on Private Sector: If government hospitals remain overcrowded, understaffed or difficult to access, citizens will continue to depend heavily on private providers.
• Strong Public System: A strong public healthcare system can itself function as an effective form of regulation by providing citizens with a credible alternative.
• Public Hospitals: Government hospitals must become a genuine healthcare option, rather than merely the last resort for those unable to afford private care.
• Primary Healthcare: Primary healthcare should be strengthened for prevention, early detection and treatment.

Role of AB-PMJAY and Insurance

• Appropriate Care: Insurance systems, including AB-PMJAY, should reward appropriate care rather than simply higher volumes of procedures.
• Clinical Audits: Clinical audits can help monitor treatment decisions.
• Evidence-Based Protocols: Treatment should follow evidence-based clinical protocols.
• Transparent Billing: Transparency in billing can protect both patients and doctors from commercial pressures.

Way Forward

• Standardised Package Rates: Develop standardised rates for healthcare episodes.
• Cost Transparency: Require pre-treatment cost estimates.
• Transparent Billing: Establish clear billing standards and audit mechanisms.
• DRG-Based Payments: Explore Diagnosis-Related Groups to move away from incentives associated with individual service-based billing.
• FDI Scrutiny: Encourage greenfield investment, while carefully examining acquisitions that may reduce competition.
• Affordable Care: Link public support such as concessional land and tax benefits with enforceable affordability obligations.
• Strengthen Public Healthcare: Improve government hospitals and primary healthcare so that citizens have a credible alternative to private providers.
• Clinical Safeguards: Strengthen clinical audits and evidence-based treatment protocols.
• Balanced Regulation: Ensure that regulation controls excessive pricing and unnecessary treatment without discouraging essential healthcare investment.

Conclusion

The Parliamentary Committee is right to focus attention on healthcare affordability and question whether the current pattern of private healthcare investment sufficiently serves the public interest.

However, private investment and profit by themselves are not the problem. The concern arises when the pursuit of financial returns begins to influence clinical priorities.

India therefore needs a healthcare system that can attract capital while ensuring that medical need remains the primary determinant of treatment. The real measure of healthcare progress should not merely be the volume of investment or growth of medical tourism, but whether citizens can enter hospitals with confidence that their treatment decisions are guided by medical necessity and affordability.

UPSC Mains Practice Question

Q. “Private investment is essential for expanding healthcare capacity, but commercial incentives can also create risks of over-medicalisation and unaffordable care.” Discuss the need to balance private investment with affordability, transparency and public interest in India’s healthcare system. (250 words, 15 marks)